Immunophenotypic analysis of erythroid dysplasia in myelodysplastic syndromes. A report from the IMDSFlow working groupTheresia M. Westers, Arjan A. van de Loosdrecht, Lisa Eidenschink Brodersen et al.|Haematologica|2016Cited by 100
Outcomes of Measurable Residual Disease in Pediatric Acute Myeloid Leukemia before and after Hematopoietic Stem Cell Transplant: Validation of Difference from Normal Flow Cytometry with Chimerism Studies and Wilms Tumor 1 Gene ExpressionDavid A. Jacobsohn, Michael A. Pulsipher, Michael R. Loken et al.|Transplantation and Cellular Therapy|2018Cited by 44
Multicenter prospective evaluation of diagnostic potential of flow cytometric aberrancies in myelodysplastic syndromes by the<scp>ELN iMDS</scp>flow working groupWolfgang Kern, Arjan van de Loosdrecht, Theresia M. Westers et al.|Cytometry Part B Clinical Cytometry|2022Cited by 30
Multicenter Prospective Evaluation of Diagnostic Potential of Flow Cytometric Aberrancies in Myelodysplastic SyndromesWolfgang Kern, Arjan A. van de Loosdrecht, Theresia M. Westers et al.|Blood|2021Cited by 0